Genflow Bioscience


Chief Executive Officer of GenFlow Biosciences Interview

GenFlow Biosciences is a biotechnology company dedicated to increasing our understanding of the factors that controls lifespan. We research, develop and commercialize therapeutic solutions to lengthen healthspan, the amount of time we live in good health. Our mission is to create biological interventions that enable longer and healthier lives.GENFLOW is dedicated to the development and commercialization of novel therapeutics targeting ageing in dogs and humans. Ageing is not a natural fatality. There is no rationale for a limited lifespan. Ageing can now be considered as a risk factor that we can treat. By treating ageing, we believe that GENFLOW can contribute to decrease healthcare costs and lessen the emotional and societal burden that comes with an ageing population.


Share it online!

If you enjoyed the article why not share it with your friends! There’s plenty more to read!

Share on facebook
Share on twitter
Share on linkedin

Related Articles

An Audience with Dr Eric Leire

Genflow Biosciences are an exciting business that are unlocking the secret to human longevity. Join us as Dr Eric Leire explains exactly how they are doing this and how in the future they plan to make your Mum, Dad or Dog live longer.


A Disruptive Approach to Longevity Therapies

At Ending Age-Related Diseases 2020, Dr. Eric Leire of Genflow Biosciences discussed his company, explaining what Genflow does and how it is funded. The company is intervening directly in the biology of aging, affecting SIRT6, which, like other sirtuins, is a known regulator of aging.


Stay up to date with our progress, news and more